Medicare Enrolled
Dr. Lowell Hart, M.D.
Medical Oncology · Fort Myers, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hart?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hart
Dr. Lowell Hart is a medical oncology specialist in Fort Myers, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hart performed 73,615 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hart received a total of $339,421 from 102 pharmaceutical and/or device companies across 1581 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hart is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 30% volume in FL
$339,421 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 39180 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗73,615
Medicare services
Top 30% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
16,320 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
13,200 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 13,000 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 7,670 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 5,940 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
4,260 | $6 | $23 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
3,500 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,530 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,524 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,332 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 890 | $1 | $28 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
724 | $65 | $229 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
642 | $96 | $336 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
417 | $11 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 416 | $0 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
377 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
287 | $103 | $378 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
151 | $10 | $42 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
150 | $1 | $6 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
138 | $2 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
119 | $50 | $189 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
119 | $1 | $3 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
99 | $23 | $84 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
97 | $7 | $69 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
82 | $25 | $156 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
79 | $23 | $79 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
79 | $52 | $178 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
77 | $15 | $56 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
64 | $25 | $89 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
50 | $18 | $59 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
47 | $30 | $156 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
46 | $50 | $206 |
| New patient office visit, complex (60-74 min) | 32 | $153 | $581 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $132 | $446 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
27 | $2 | $8 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
27 | $65 | $197 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
27 | $2 | $11 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
22 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $143 | $463 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $142 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
23.4% high complexity
70.4% medium
6.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$339,421
Total received (2018-2024)
Avg $48,489/year across 7 years
Top 3% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
102
Companies
1,581
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,212
2023
$9,302
2022
$6,213
2021
$8,963
2020
$51,099
2019
$159,454
2018
$95,177
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$4,948
E.R. Squibb & Sons, L.L.C.
$507
AstraZeneca Pharmaceuticals LP
$475
Janssen Biotech, Inc.
$310
Merck Sharp & Dohme LLC
$304
BeiGene USA, Inc.
$248
Incyte Corporation
$247
PFIZER INC.
$230
Gilead Sciences, Inc.
$222
Celgene Corporation
$174
Bayer Healthcare Pharmaceuticals Inc.
$155
Mirati Therapeutics, Inc.
$144
Daiichi Sankyo Inc.
$101
Eisai Inc.
$92
GlaxoSmithKline, LLC.
$78
Takeda Pharmaceuticals U.S.A., Inc.
$76
ABBVIE INC.
$75
Regeneron Healthcare Solutions, Inc.
$74
TerSera Therapeutics LLC
$52
SOBI, INC
$48
Lilly USA, LLC
$47
Exelixis Inc.
$42
Genmab U.S., Inc.
$42
Pharmacosmos Therapeutics Inc.
$40
Adaptive Biotechnologies Corporation
$35
PUMA BIOTECHNOLOGY, INC.
$35
JAZZ PHARMACEUTICALS INC.
$33
Rigel Pharmaceuticals, Inc.
$33
Astellas Pharma US Inc
$32
Myriad Genetic Laboratories, Inc.
$30
Sumitomo Pharma America, Inc.
$30
Stemline Therapeutics Inc.
$29
Kyowa Kirin, Inc.
$26
SpringWorks Therapeutics, Inc.
$25
Legend Biotech USA Inc.
$24
ARRAY BIOPHARMA INC
$23
GENZYME CORPORATION
$22
Epizyme, Inc.
$20
ADC Therapeutics America, Inc.
$19
Genentech USA, Inc.
$16
SERVIER PHARMACEUTICALS LLC
$14
Alexion Pharmaceuticals, Inc.
$14
Iovance Biotherapeutics, Inc.
$9
Janssen Scientific Affairs, LLC
$8
Sirtex Medical Inc
$7
Top 3 companies account for 64.4% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$135,154
Novartis Pharmaceuticals Corporation
$43,370
Boehringer Ingelheim Pharmaceuticals, Inc.
$25,017
Genentech USA, Inc.
$24,164
F. Hoffmann-La Roche AG
$15,170
AstraZeneca Pharmaceuticals LP
$12,456
Seagen Inc.
$10,300
Merck Sharp & Dohme Corporation
$8,185
PFIZER INC.
$8,173
Janssen Biotech, Inc.
$8,129
Veracyte, Inc.
$5,851
Daiichi Sankyo Inc.
$4,703
NOVARTIS PHARMACEUTICALS CORPORATION
$4,105
Seattle Genetics, Inc.
$3,453
TESARO, Inc.
$2,390
Karyopharm Therapeutics Inc.
$2,287
Pharmacyclics LLC, An AbbVie Company
$2,183
E.R. Squibb & Sons, L.L.C.
$1,919
Jazz Pharmaceuticals Inc.
$1,760
Blueprint Medicines Corporation
$1,743
Foundation Medicine, Inc.
$1,595
Epizyme, Inc.,
$1,490
Celgene Corporation
$1,406
Merck Sharp & Dohme LLC
$1,104
Boehringer Ingelheim International GmbH
$1,058
GENZYME CORPORATION
$826
Incyte Corporation
$789
Amgen Inc.
$741
Gilead Sciences, Inc.
$619
Exelixis Inc.
$598
BeiGene USA, Inc.
$537
Eisai Inc.
$511
Athenex Pharmaceutical Division, LLC
$500
NanoString Technologies, Inc.
$400
Bayer HealthCare Pharmaceuticals Inc.
$335
Astellas Pharma US Inc
$315
Bayer Healthcare Pharmaceuticals Inc.
$314
GlaxoSmithKline, LLC.
$299
G1 Therapeutics, Inc.
$290
Takeda Pharmaceuticals U.S.A., Inc.
$269
Puma Biotechnology, Inc.
$258
Clovis Oncology, Inc.
$244
Ipsen Biopharmaceuticals, Inc
$235
Agios Pharmaceuticals, Inc.
$219
Mirati Therapeutics, Inc.
$214
Regeneron Healthcare Solutions, Inc.
$214
EISAI INC.
$198
ARRAY BIOPHARMA INC
$190
EMD Serono, Inc.
$167
JAZZ PHARMACEUTICALS INC.
$165
CTI BioPharma Corp.
$158
Spectrum Pharmaceuticals Inc.
$158
TerSera Therapeutics LLC
$150
Adaptive Biotechnologies Corporation
$143
Verastem, Inc.
$138
Dova Pharmaceuticals
$135
ABBVIE INC.
$119
PharmaEssentia USA Corporation
$92
Janssen Pharmaceuticals, Inc
$88
AbbVie, Inc.
$86
SOBI, INC
$85
Kyowa Kirin, Inc.
$81
SANOFI-AVENTIS U.S. LLC
$75
Pharmacyclics LLC, an AbbVie Company
$67
Kite Pharma, Inc.
$67
Taiho Oncology, Inc.
$61
Alnylam Pharmaceuticals Inc.
$60
Sumitomo Pharma America, Inc.
$60
Myriad Genetic Laboratories, Inc.
$53
Stemline Therapeutics Inc.
$52
PUMA BIOTECHNOLOGY, INC.
$48
EUSA Pharma (US) LLC
$48
Sirtex Medical Inc
$46
Epizyme, Inc.
$43
Myovant Sciences Inc.
$43
Genmab U.S., Inc.
$42
Pharmacosmos Therapeutics Inc.
$40
AMAG Pharmaceuticals, Inc.
$39
MENARINI SILICON BIOSYSTEMS, INC.
$38
ADC Therapeutics America, Inc.
$37
Rigel Pharmaceuticals, Inc.
$33
MorphoSys, US Inc.
$32
Helsinn Therapeutics (U.S.), Inc.
$32
Alexion Pharmaceuticals, Inc.
$30
GE HEALTHCARE
$30
Aurobindo Pharma USA, Inc.
$28
SERVIER PHARMACEUTICALS LLC
$28
SpringWorks Therapeutics, Inc.
$25
Legend Biotech USA Inc.
$24
AbbVie Inc.
$20
Sobi, Inc
$19
Advanced Accelerator Applications
$18
ImmunoGen, Inc.
$18
Otsuka America Pharmaceutical, Inc.
$18
Heron Therapeutics, Inc.
$17
Acrotech Biopharma Inc.
$16
Deciphera Pharmaceuticals Inc.
$14
Secura Bio, Inc.
$13
Global Blood Therapeutics, Inc.
$13
INSYS Therapeutics Inc
$11
Iovance Biotherapeutics, Inc.
$9
Janssen Scientific Affairs, LLC
$8
Top 3 companies account for 60.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYL719 · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · Copiktra · Creon · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERLEADA · Elahere · Enhertu · Epkinly · FERAHEME · FOUNDATIONACT · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · HYQVIA · Halaven · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · Marqibo · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCREVUS · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Oral Paclitaxel · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROSIGNA ASSAY · Padcev · Perjeta · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rituxan · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
11
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
LEE MEMORIAL HOSPITAL
8.0 mi
8.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hart is a mixed practice specialist, with above-average Medicare volume (top 30% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hart experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Hart performed 16,320 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hart receive payments from pharmaceutical companies?
Yes. Dr. Hart received a total of $339,421 from 102 companies across 1,581 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hart's costs compare to other medical oncologists in Fort Myers?
Dr. Hart's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Fort Myers
Browse medical oncologists in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology